Phaedra Chrousos is Director at Vanda Pharmaceuticals Inc. (VNDA). They have made 1 open-market trade across 1 company since 2021, most recently 2026-06-04.
CIK 0001774518
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VNDA | 164,950 | $666K |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VNDA | SELL | 2021-06-14 | 2021-06-15 | $19.34 | $40K | +7.5% | +0.1% | -13.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.